Manish Sahni, MD , provides personalized care to help patients safely and effectively incorporate this FDA-approved option into their weight loss journey
non-oral contraceptive methods should be considered [1] Optimization strategy : Tirzepatide monotherapy should be optimized to the maximally tolerated dose with confirmed adherence before considering phentermine addition Cost considerations : Both medications can be expensive, particularly tirzepatide, which may limit accessibility Any decision to combine these medications should involve shared decision-making with written informed consent, thorough evaluation of the patient's medical history, current health status, weight loss goals, and potential contraindications
(1984) The meaning of surgical margins
Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production
The underlying mechanism relates to body fats role in estrogen production
Single-Molecule Fluorescence Imaging for Ultrasensitive DNA Methyltransferase Activity Measurement and Inhibitor Screening